Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Inclusion Criteria (for subjects who participated in trials 000129 or 000130): * Written informed consent prior to performance of any trial-related activity for the 000131 trial * Has completed participation in trial 000129 or 000130 Exclusion Criteria (for subjects who participated in trials 000129 or 000130): * Hyponatraemia (serum sodium level \<135 mmol/L) at Visit 7 in trial 000129 or 000130 * Withdrawal from clinical trial 000129 or 000130 Inclusion Criteria (for subjects who did not participate in trials 000129 or 000130): * Written informed consent prior to performance of any trial-related activity * Adult ≥20 years of age * Nocturia symptoms present for ≥6 months prior to trial entry at Visit 1a * Nocturnal polyuria at the end of screening period prior to Visit 1b * Bothered by nocturia on the Hsu 5-point Likert bother scale at Visit 1a and Visit 1b * Has given agreement about contraception during the trial Exclusion Criteria (for subjects who did not participate in trials 000129 or 000130): * Early withdrawal from clinical trial 000129 or 000130 * Evidence of any significant voiding dysfunction resulting in abnormally low bladder capacity at the end of the screening period prior to Visit 1b * History or evidence of significant obstructive sleep apnoea * History or diagnosis of any of the following urological diseases: * Interstitial cystitis or bladder pain disorder * In males, suspicion of moderate or severe benign prostate hyperplasia (BPH), defined as…